1800-272-662
Shopping Cart 0
countryflagAU
Login

Neuronetics Inc

Healthcare US STIM

1.22USD
-0.1(7.58%)

Last update at 2026-03-10T20:29:00Z

Day Range

1.201.33
LowHigh

52 Week Range

1.035.07
LowHigh

Fundamentals

  • Previous Close 1.32
  • Market Cap62.40M
  • Volume1064878
  • P/E Ratio-
  • Dividend Yield-%
  • EBITDA-23.45600M
  • Revenue TTM73.22M
  • Revenue Per Share TTM2.52
  • Gross Profit TTM 49.72M
  • Diluted EPS TTM-0.9

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Analyst Recommendations

Financials

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Income before tax -37.15900M -31.19300M -27.45300M -29.04400M -24.09700M
Minority interest - - - - -
Net income -39.20700M -35.60200M -32.27700M -34.30000M -24.09700M
Selling general administrative 25.52M 25.55M 18.24M 17.46M 13.67M
Selling and marketing expenses 49.98M 37.75M 32.56M 42.99M 38.26M
Gross profit 49.72M 43.66M 37.69M 47.27M 40.33M
Reconciled depreciation 1.65M 1.06M 0.94M 1.06M 0.88M
Ebit -35.11100M -27.56400M -22.30900M -26.93000M -20.40900M
Ebitda -31.26000M -26.11400M -21.06600M -24.29400M -19.52700M
Depreciation and amortization 3.85M 1.45M 1.24M 2.64M 0.88M
Non operating income net other 2.20M - -0.62200M 1.57M -0.57500M
Operating income -35.11100M -27.56400M -22.30900M -26.93000M -19.83400M
Other operating expenses 100.32M 82.88M 71.55M 89.59M 72.61M
Interest expense 4.25M 4.02M 4.52M 3.69M 3.69M
Tax provision - - - - -
Interest income - - - 3.69M 3.69M
Net interest income -4.25100M -4.01900M -4.52200M -3.68500M -3.68800M
Extraordinary items - - - - -
Non recurring - - - - -
Other items - - - - -
Income tax expense 2.05M 4.41M 4.82M 5.26M -0.57500M
Total revenue 65.21M 55.31M 49.24M 62.66M 52.78M
Total operating expenses 84.83M 71.22M 60.00M 74.20M 60.16M
Cost of revenue 15.48M 11.65M 11.55M 15.39M 12.45M
Total other income expense net -2.04800M -3.62900M -5.14400M -2.11400M -0.57500M
Discontinued operations - - - - -
Net income from continuing ops -37.15900M -31.19300M -27.45300M -29.04400M -24.09700M
Net income applicable to common shares -37.15900M -31.19300M -27.45300M -29.04400M -24.09700M
Preferred stock and other adjustments - - - - -
Breakdown 2023-12-31 2022-12-31 2021-12-31 2020-12-31 2019-12-31
Type yearly yearly yearly yearly yearly
Date 2023-12-31 2022-12-31 2021-12-31 2020-12-31 2019-12-31
Total assets 115.83M 116.88M 141.22M 78.66M 100.17M
Intangible assets 4.20M - - - 1.20M
Earning assets - - - - -
Other current assets 7.28M 2.17M 4.65M 3.28M 2.52M
Total liab 81.64M 59.82M 56.05M 53.16M 52.32M
Total stockholder equity 34.19M 57.06M 85.17M 25.49M 47.85M
Deferred long term liab - 0.83M 6.76M 1.74M 3.78M
Other current liab 12.60M 14.84M 8.23M 7.32M 9.03M
Common stock 0.29M 0.27M 0.26M 0.19M 0.19M
Capital stock 0.29M 0.27M 0.26M 0.19M 0.19M
Retained earnings -376.08100M -345.89200M -308.73300M -277.54000M -250.08700M
Other liab - 0.83M 1.47M 1.74M 2.11M
Good will - - - - -
Other assets 0.00000M 9.20M 167.12M 12.91M 5.61M
Cash 59.68M 70.34M 94.14M 48.96M 75.71M
Cash and equivalents - - - - -
Total current liabilities 19.81M 33.20M 15.70M 13.68M 27.69M
Current deferred revenue 1.62M 1.98M 2.50M 2.02M 2.23M
Net debt 2.80M -30.59500M -54.59700M -10.62200M -41.38200M
Short term debt 0.84M 13.95M 0.67M 0.59M 11.81M
Short long term debt - 13.12M - - 11.25M
Short long term debt total 62.47M 39.74M 39.54M 38.34M 34.33M
Other stockholder equity 409.98M 402.68M 393.64M 302.84M 297.75M
Property plant equipment - 1.99M 5.10M 0.73M 4.90M
Total current assets 93.79M 98.77M 115.33M 65.01M 88.45M
Long term investments 0.66M 0.36M 1.70M 2.33M 1.73M
Net tangible assets - 57.06M 85.17M 25.49M 46.65M
Short term investments 0.91M 1.54M 2.20M 1.89M 0.88M
Net receivables 17.84M 13.82M 7.78M 7.17M 6.57M
Long term debt 59.28M 22.83M 35.34M 34.62M 19.90M
Inventory 8.09M 8.90M 6.56M 3.72M 2.77M
Accounts payable 4.75M 2.43M 4.30M 3.75M 4.62M
Total permanent equity - - - - -
Noncontrolling interest in consolidated entity - - - - -
Temporary equity redeemable noncontrolling interests - - - - -
Accumulated other comprehensive income - - - - -2.20700M
Additional paid in capital - - - - -
Common stock total equity - 0.27M - 0.19M 0.19M
Preferred stock total equity - - - - -
Retained earnings total equity - -345.89200M - -277.54000M -250.08700M
Treasury stock - - - - -
Accumulated amortization - - - - -
Non currrent assets other 12.80M 11.57M 19.09M 7.17M 5.08M
Deferred long term asset charges - - - - -
Non current assets total 22.04M 18.11M 25.89M 13.64M 11.72M
Capital lease obligations 3.19M 3.79M 4.21M 3.71M 3.18M
Long term debt total - 22.83M - 34.62M 19.90M
Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Investments 10.00M -9.83900M -0.73000M -0.81300M -1.01100M
Change to liabilities 4.64M 0.49M -2.81800M 1.85M 0.51M
Total cashflows from investing activities 6.73M -9.83900M -0.73000M -0.81300M -1.01100M
Net borrowings -0.09100M - 1.68M 2.50M 2.50M
Total cash from financing activities 0.21M 83.01M 2.37M 2.42M 97.04M
Change to operating activities 7.26M -0.63000M -5.07500M -6.09400M -0.35200M
Net income -37.15900M -31.19300M -27.45300M -29.04400M -24.09700M
Change in cash -23.80100M 45.18M -26.75100M -28.87500M 75.44M
Begin period cash flow 94.14M 48.96M 75.71M 104.58M 29.15M
End period cash flow 70.34M 94.14M 48.96M 75.71M 104.58M
Total cash from operating activities -30.73900M -27.98300M -28.39000M -30.48200M -20.59100M
Issuance of capital stock 0.00000M 80.97M 0.00000M 0.00000M 100.00M
Depreciation 1.65M 1.06M 0.94M 1.06M 0.88M
Other cashflows from investing activities 10.00M -7.48600M -7.48600M -7.48600M -7.48600M
Dividends paid - - - - -
Change to inventory -2.58700M -3.44400M -0.94500M -0.30600M -0.43500M
Change to account receivables -6.31700M -3.05400M -0.59700M -0.95000M -1.35300M
Sale purchase of stock 0.30M - 0.69M 2.42M 97.04M
Other cashflows from financing activities 6.73M 2.03M 41.23M 2.42M -2.96000M
Change to netincome 8.75M 8.79M 4.40M 3.43M 3.14M
Capital expenditures 3.27M 2.35M 0.73M 0.81M 1.01M
Change receivables -6.31700M - -0.59700M -0.95000M -1.35300M
Cash flows other operating -0.41500M - -3.11400M -7.28200M -0.07100M
Exchange rate changes - - - - -
Cash and cash equivalents changes -23.80100M - -26.75100M -28.87500M 75.44M
Change in working capital -4.77500M -6.63700M -8.27500M -6.91300M -1.58300M
Stock based compensation 8.75M 7.87M 4.40M 3.43M 1.74M
Other non cash items 0.80M 0.92M 1.37M 0.98M 1.07M
Free cash flow -34.00800M -30.33600M -29.12000M -31.29500M -21.60200M

Peer Comparison

Sector: Healthcare Industry: Diagnostics & Research

Company Change (USD) Price (USD) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x) Enterprise Value to Revenue (x) Enterprise Value to EBITDA (x)
STIM
Neuronetics Inc		 -0.1 7.58% 1.22 - - 1.80 3.76 1.83 -5.5841
TMO
Thermo Fisher Scientific Inc		 -9.89 1.94% 500.08 34.71 23.87 4.62 4.43 5.29 20.89
DHR
Danaher Corporation		 -3.58 1.80% 195.22 29.09 28.01 5.67 3.20 6.00 19.09
A
Agilent Technologies Inc		 -1.21 1.04% 115.43 34.36 26.39 6.59 7.14 6.78 23.56
IDXX
IDEXX Laboratories Inc		 -11.6 1.90% 598.85 49.99 45.66 11.29 27.85 11.46 34.46

Reports Covered

Stock Research & News

View All

Profile

Neuronetics, Inc., a commercial stage medical technology company, designs, develops, and markets products for patients with neurohealth disorders in the United States and internationally. The company offers NeuroStar Advanced Therapy System, a non-invasive and non-systemic office-based treatment to treat adult patients with major depressive disorder. Its NeuroStar Advanced Therapy System uses transcranial magnetic stimulation to create a pulsed, MRI-strength magnetic field that induces electrical currents designed to stimulate specific areas of the brain associated with mood. The company sells its products through its sales and customer support team to psychiatrists. The company was incorporated in 2001 and is headquartered in Malvern, Pennsylvania.

Neuronetics Inc

3222 Phoenixville Pike, Malvern, PA, United States, 19355

Key Executives

Name Title Year Born
Mr. Keith J. Sullivan Pres, CEO & Director 1958
Mr. Stephen J. Furlong M.S. Sr. VP, CFO & Treasurer 1965
Mr. W. Andrew Macan Sr. VP, Gen. Counsel, Chief Compliance Officer, Sec. & Member of Office of the Pres 1973
Ms. Sara Grubbs VP of Sales NA
Ms. Claire Sears VP of Marketing NA
Ms. Kara Thornton VP of HR & Sr. Director NA
Mr. Keith J. Sullivan President, CEO & Director 1958
Mr. Stephen J. Furlong M.S. Executive VP, CFO & Treasurer 1964
Mr. W. Andrew Macan Executive VP, GC, Chief Compliance Officer & Corporate Secretary 1973
Mr. Rusty Page Senior VP of Operations & Quality NA

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.